News search

This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. 

A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young men

The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions

The CNIC has been allocated €405,625 for its involvement in GRACE, a project focused on developing innovative strategies to improve the detection and management of cardiovascular diseases.

The findings of this study have been key for the development of REACT, a new research project, that will count on the collaboration of Santander Bank, and will expand the study of the age group for the prevention of cardiovascular diseases, which will include 8,000 new participants.

iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations.

The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases

A team of scientists from the CNIC and the CSIC has identified a key mechanism in the development of atherosclerosis in patients with the rare genetic disease Hutchinson-Gilford progeria syndrome